MK-0646
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for MK-0646, covering 2011-12-05 to 2023-08-04. Get the full timeline:
Most recent: Clinical Trial Update: MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1, Phase 2]